Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma

Fig. 5

Differences in mean Spiromax PASAPQ scores vs mean Turbuhaler PASAPQ scores at baseline* and week 12* (a) performance domains (b) convenience domains. BFT budesonide–formoterol Turbuhaler, BFS budesonide–formoterol Spiromax, PASAPQ Patient Satisfaction and Preference Questionnaire for Inhalation Devices. Positive Y-axis values indicate that Spiromax performed better than Turbuhaler; negative Y-axis values indicate that Turbuhaler performed better than Spiromax

Back to article page